The association between PAI-1-675 4G/5G polymorphism and type 2 diabetes mellitus

被引：1
|
作者：
Chen, L. [1 ]
Li, S-Y. [1 ]
Liu, M. [1 ]
机构：
[1] Tianjin Gong An Hosp, Dept Endocrinol, Tianjin 300042, Peoples R China
来源：
CELLULAR AND MOLECULAR BIOLOGY | 2017年 / 63卷 / 07期
关键词：
Type 2 diabetes mellitus; PAI-1; Polymorphism; Association; PLASMINOGEN-ACTIVATOR INHIBITOR-1; GENE; POPULATION; RISK;
D O I：
10.14715/cmb/2017.63.7.11
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
In this study, we aimed to analyze the association between plasminogen activator inhibitor 1 (PAI-1)-675 4G/5G polymorphism and type 2 diabetes mellitus (T2DM) risk. We included in 187 T2DM patients and 186 heathy controls between 2014 and 2017 from Tianjin Gong An Hospital, China. All patients and controls were ethnically Chinese Han population. The primers and polymerase chain reaction (PCR) conditions were performed. Results from this case-control study suggested that PAI-1-675 4G/5G polymorphism was not associated with T2DM risk in four genetic models. Additionally, PAI-1-675 4G/5G polymorphism was not associated with clinical and laboratory characteristics, such as age, gender, body mass index, systolic blood pressure, diastolic blood pressure, total cholesterol, triglycerides, and HbA1c. In conclusion, this case-control study suggested that PAI-1-675 4G/5G polymorphism was not associated with T2DM risk in this population.
引用
收藏
页码：66 / 68
页数：3
相关论文
共 50 条
  • [41] PAI-1 4G/5G Polymorphism and Plasma Levels Association in Patients with Coronary Artery Disease
    Lima, Luciana Moreira
    Carvalho, Maria das Gracas
    Fonseca Neto, Cirilo Pereira
    Faria Garcia, Jose Carlos
    Sousa, Marinez Oliveira
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (06) : 462 - 467
  • [42] The 4G/4G Genotype of the PAI-1 (Serpine-1) 4G/5G Polymorphism Is Associated With Decreased Lung Allograft Utilization
    Sapru, A.
    Zaroff, J. G.
    Pawlikowska, L.
    Liu, K. D.
    Khush, K. K.
    Baxter-Lowe, L. A.
    Hayden, V.
    Menza, R. L.
    Convery, M.
    Lo, V.
    Poon, A.
    Kim, H.
    Young, W. L.
    Kukreja, J.
    Matthay, M. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (07) : 1848 - 1854
  • [43] Pai-1 4G/5G polymorphism affects the risk of microvascular complications in type 1 and in type 2 diabetes with no interaction with the ACE I/D polymorhism
    Pucci, Laura
    Lucchesi, Daniela
    Triscornia, Stefano
    Fotino, Carmen
    Caricato, Francesco
    Miccoli, Roberto
    Del Prato, Stefano
    Penno, Giuseppe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 82 - 83
  • [44] The 4G/4G Genotype Of The PAI-1 4G/5G Polymorphism Is Associated With Decreased Lung Graft Utilization And Worse Oxygenation
    Sapru, A.
    Zaroff, J.
    Pawlikowaska, L.
    Liu, K.
    Baxter-Lowe, L.
    Babcock, W.
    Hayden, V.
    Menza, R.
    Khush, K.
    Convery, M.
    Landeck, M.
    Matthay, M. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [45] PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitusDer PAI-1-4G/5G-Insertion/Deletion-Promoter-Polymorphismus und mikrovaskuläre Komplikationen in Typ 2 Diabetes mellitus
    Marion Funk
    Georg Endler
    Markus Exner
    Rodrig Marculescu
    Lukas Endler
    Heidemarie Abrahamian
    Harald Mauler
    Angelika Grimm
    Marianne Raith
    Christine Mannhalter
    Rudolf Prager
    Karl Irsigler
    Oswald F. Wagner
    Wiener klinische Wochenschrift, 2005, 117 : 707 - 710
  • [46] RELATIONSHIP BETWEEN PAI-1 PROMOTOR REGION GENE 4G/5G POLYMORPHISM AND PULMONARY THROMBOEMBOLISM
    Ma Hanying
    Han Hong-ya
    Yang Qing
    Nie-Bin
    Liu Rui-fang
    Chai Meng
    Zhang Ou
    Guo Wen
    Zhou Yu-jie
    HEART, 2013, 99 : E65 - E65
  • [47] Plasminogen activator inhibitor I (PAI-I) -675 5G/4G polymorphism in patients with coronary artery disease
    Apergis, G
    Belia, M
    Bratsas, A
    Pavlou, E
    Brili, S
    Gafou, A
    Georgopoulos, J
    Stefanadis, C
    Andrioti, E
    PROCEEDINGS OF THE 18TH INTERNATIONAL CONGRESS ON THROMBOSIS, 2004, : 31 - 35
  • [48] Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with type 2 diabetes risk
    Zhao, Luqian
    Huang, Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2013, 6 (08): : 632 - 640
  • [49] Association Between Plasminogen Activator Inhibitor-1-675 4G/5G Insertion/Deletion Polymorphism and Chronic Obstructive Pulmonary Disease
    Essa, Enas S.
    ElWahsh, Rabab A.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 13 (06) : 756 - 759
  • [50] 4G/5G polymorphism modulates PAI-1 circulating levels in obese women
    Fernandes, Karla S.
    Sandrim, Valeria C.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 364 (1-2) : 299 - 301
12345